PEOPLE - Cambridge Antibody Technology (CAT) makes the following appointments:
This article was originally published in Clinica
Executive Summary
Cambridge Antibody Technology (CAT) has made two executive director appointments; the US company's vice-president of research, Dr Kevin Johnson, is research director and vice-president of medical development, David Glover, joins as medical director.